Related Content
December 9, 2015 — BioVentrix Inc. has achieved the first implantation of its micro-anchor heart failure (HF) technology ...
December 09, 2015
July 1, 2014 — BioVentrix announced the successful completion of it 50th clinical case using the Revivent myocardial ...
July 01, 2014
January 22, 2014 — BioVentrix’s Revivent-TC Ventricular Enhancement System was implanted in a man via Less Invasive ...
January 22, 2014
October 11, 2013 — Bioventrix announced the presentation of scientific data demonstrating the durability of its Revivent ...
October 11, 2013
August 22, 2013 – BioVentrix announced the successful first use of its Revivent Myocardial Anchoring System via the Less ...
August 22, 2013
July 23, 2013 — BioVentrix, known for the Less Invasive Ventricular Enhancement (LIVE) procedure for the treatment of ...
July 23, 2013January 3, 2013 — BioVentrix announced it has received CE mark for its Revivent myocardial anchoring system, which makes ...
January 03, 2013April 24, 2012 – BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, will ...
April 24, 2012
August 12, 2010 – A 52-year-old male heart failure patient in Krakow, Poland, became the first human to receive the ...
August 12, 2010October 17, 2007 - After a three-week trial, a jury rendered a verdict of "willful" patent infringement in a dispute ...
October 16, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now